Main
>
RHEUMATOLOGY>RHEUMATOID ARTHRITIS
>
Treatment
>
p38 MAP Kinase Inhibitor Program
>
Compound (Co.: USA. Arq.)
>
Status (11.03)
>
PreClinical Testing
PreClinical Testing's products
This section has no products